Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: A prospective randomized study

Urological Research

Volumn 40, Issue 6, 2012, Pages 757-762

  Lu, Jian Lin ^a   Tang, Qing Lai ^a   De Liu, Fa ^a   Hui, Ju Hong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Intramural ureter; Naftopidil; Stone; Tolterodine

Indexed keywords

NAFTOPIDIL; TOLTERODINE;

ADULT; ARTICLE; BLADDER IRRITATION; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; INTRAMURAL URETERAL STONE; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHINITIS; URETER STONE; URINARY SENSATION SCALE; URINARY URGENCY; VISUAL ANALOG SCALE; XEROSTOMIA;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; BENZHYDRYL COMPOUNDS; CRESOLS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; NAPHTHALENES; PHENYLPROPANOLAMINE; PIPERAZINES; PROSPECTIVE STUDIES; URETERAL CALCULI;

EID: 84874112113     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-012-0498-7     Document Type: Article

References (26)

1. Zhou SG, Lu JL, Hui JH (2011) Comparing efficacy of a1Dreceptor antagonist naftopidil and a1A/D-receptor antagonist tamsulosin in management of distal ureteral stones. World J Urol 29:767-771
2. Dellabella M, Milanese G, Muzzonigro G (2003) Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170:2202-2205
3. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K (2007) Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14:749-753
4. Sigala S, Dellabella M, Milanese G et al (2004) Alpha-1adrenoceptor subtypes in men juxtavesical ureters: molecular and pharmacological characterization. Eur Urol 3:119
5. Cervenakov I, Fillo J, Mardiak J et al (2002) Speedy elimination of ureterolithiasis in lower part of ureters with the alpha-1 blocker -tamsulosin. Int Urol Nephrol 34:25-29
6. Canda AE, Turna B, Cinar GM, Nazli O (2007) Physiology and pharmacology of the human ureter: basis for current and future treatments. Urol Int 78:289-298
7. Sigala S, Dellabella M, Milanese G et al (2005) Evidence for the presence of a1 adrenoceptor subtypes in the human ureter. Neurourol Urodynam 24:142-148
8. Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T (2006) Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int 97:747-751
9. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H (2005) The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 713:2010-2012
10. Porpiglia F, Vaccino D, Billia M et al (2006) Corticosteroids and tamsulosin in the medical expulsive therapy for symptomatic distal ureter stones: single drug or association Eur Urol 50:339-344
11. Takei R, Ikegaki I, Shibata K, Tsujimoto G, Asano T (1999) Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol 79:447-454
12. Hubner WA, Irby P, Stoller ML (1993) Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 24:172
13. Ueno A, Kawamura T, Ogawa A, Takayasu H (1977) Relation of spontaneous passage of ureteral calculi to size. Urology 10:544
14. Coll DM, Varanelli MJ, Smith RC (2002) Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 178:101
15. Shokeir AA (2001) Renal colic: pathophysiology, diagnosis and treatment. Eur Urol 39:241-249
16. Borghi L, Meschi T, Amato F et al (1994) Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol 152:1095
17. Porpiglia F, Destefanis P, Fiori C, Fontana D (2000) Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 56:579
18. Morita T, Wada I, Saeki H, Tsuchida S, Weiss RM (1987) Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. J Urol 137:132-135
19. Sun XZ, He L, Ge WH, Lv JL (2009) Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. J Urol 181:1716-1720
20. Agrawal M, Gupta M, Gupta A, Agrawal A, Sarkari A, Lavania P (2009) Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones. Urology. 73:706-709
21. Al-Ansari Abdulla, Al-Naimi Abdulla, Alobaidy Abdulkader et al (2010) Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients. Urology 75:4-7
22. Lv JL, Tang QN, Hui JH (2011) Efficacy of tolterodine for medical treatment of intramural ureteral stone with vesical irritability. Urol Res 39:213-216
23. Elinoff V, Bavendam T, Glasser DB et al (2006) Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial. Int J Clin Pract 60:745-751
24. Roberts R, Bavendam T, Glasser DB et al (2006) Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial. Int J Clin Pract 60:752-758
25. Erturhan S, Erbagci A, Yagci F, Celik M, Solakhan M, Sarica K (2007) Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones. Urology 69(4):633-636
26. Brewster-Jordan JL, Guan Z, Green HL, et al. Establishing the content validity of the Urinary Sensation Scale (USS). Presented at a meeting of the international society for pharmacoeconomics and outcomes research, Washington, DC, 15-18 May 2005